Literature DB >> 29699289

Angiogenesis in the human corpus luteum.

Norihiro Sugino1, Aki Matsuoka1, Ken Taniguchi1, Hiroshi Tamura1.   

Abstract

Angiogenesis is important for the formation and development of the corpus luteum and for maintenance of luteal function. Blood vessel regression is an important physiological phenomenon in the corpus luteum, which is associated with tissue involution during structural luteolysis. Angiogenesis actively occurs during the early luteal phase and is completed by the mid-luteal phase. Perivascular cells (pericytes) increase in number from the early luteal phase to the mid-luteal phase, suggesting that blood vessels are gradually stabilized until the mid-luteal phase. In the corpus luteum undergoing luteolysis, blood vessels and pericytes decrease in number, which is related to structural involution. In the corpus luteum of early pregnancy, the number of blood vessels with pericytes increases, suggesting that angiogenesis occurs again, accompanied by blood vessel stabilization. These changes in vasculature of the corpus luteum are regulated by the collaboration with vascular endothelial growth factor, which is involved in proliferation of vascular endothelial cells, and angiopoietins, which are involved in stabilization of blood vessels. This review focuses on angiogenesis, blood vessel stabilization and blood vessel regression during the divergent phases of luteal formation, luteal regression and luteal rescue by pregnancy. (Reprod Med Biol 2008; 7: 91-103).

Entities:  

Keywords:  angiogenesis; angiopoietin; blood flow; corpus luteum; vascular endothelial growth factor

Year:  2008        PMID: 29699289      PMCID: PMC5904659          DOI: 10.1111/j.1447-0578.2008.00205.x

Source DB:  PubMed          Journal:  Reprod Med Biol        ISSN: 1445-5781


  77 in total

Review 1.  Tight junction proteins.

Authors:  L González-Mariscal; A Betanzos; P Nava; B E Jaramillo
Journal:  Prog Biophys Mol Biol       Date:  2003-01       Impact factor: 3.667

2.  Angiogenesis in the human corpus luteum: localization and changes in angiopoietins, tie-2, and vascular endothelial growth factor messenger ribonucleic acid.

Authors:  C Wulff; H Wilson; P Largue; W C Duncan; D G Armstrong; H M Fraser
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 3.  Regulation and action of angiogenic factors in the primate ovary.

Authors:  R L Stouffer; J C Martínez-Chequer; T A Molskness; F Xu; T M Hazzard
Journal:  Arch Med Res       Date:  2001 Nov-Dec       Impact factor: 2.235

4.  Cyclic changes of vasculature and vascular phenotypes in normal human ovaries.

Authors:  T Suzuki; H Sasano; R Takaya; T Fukaya; A Yajima; H Nagura
Journal:  Hum Reprod       Date:  1998-04       Impact factor: 6.918

5.  Blood vessel maturation: vascular development comes of age.

Authors:  D C Darland; P A D'Amore
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

6.  Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary.

Authors:  N Ravindranath; L Little-Ihrig; H S Phillips; N Ferrara; A J Zeleznik
Journal:  Endocrinology       Date:  1992-07       Impact factor: 4.736

7.  Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy.

Authors:  N Sugino; S Kashida; S Takiguchi; A Karube; H Kato
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

8.  Color flow pulsed Doppler ultrasound in diagnosing luteal phase defect.

Authors:  J L Glock; J R Brumsted
Journal:  Fertil Steril       Date:  1995-09       Impact factor: 7.329

9.  Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.

Authors:  Napoleone Ferrara; Gretchen Frantz; Jennifer LeCouter; Lisa Dillard-Telm; Thinh Pham; Aparna Draksharapu; Thomas Giordano; Franklin Peale
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

10.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  4 in total

1.  C/EBPβ regulates Vegf gene expression in granulosa cells undergoing luteinization during ovulation in female rats.

Authors:  Masahiro Shinagawa; Isao Tamura; Ryo Maekawa; Shun Sato; Yuichiro Shirafuta; Yumiko Mihara; Maki Okada-Matsumoto; Toshiaki Taketani; Hiromi Asada; Hiroshi Tamura; Norihiro Sugino
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

2.  Characterization of the roles of amphiregulin and transforming growth factor β1 in microvasculature-like formation in human granulosa-lutein cells.

Authors:  Hui Li; Hsun-Ming Chang; Saijiao Li; Christian Klausen; Zhendan Shi; Peter C K Leung
Journal:  Front Cell Dev Biol       Date:  2022-08-24

3.  Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy.

Authors:  Li Wang; Meili Pei; Ting Yang; Juan Zhao; Xiaofeng Yang
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-30       Impact factor: 3.007

4.  Parenteral Copper Administration at the Beginning of a Fixed-Time Artificial Insemination Protocol in Beef Cattle: Effect on Ovarian Function and Pregnancy Rates.

Authors:  Juan Patricio Anchordoquy; Santiago Nicolás Lorenti; Gustavo Sebastián Polero; Nicolás Agustín Farnetano; Diana Esther Rosa; Mariana Carolina Fabra; Ana Cristina Carranza-Martin; Noelia Nikoloff; Cecilia Cristina Furnus; Juan Mateo Anchordoquy
Journal:  Biol Trace Elem Res       Date:  2021-06-26       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.